D. Haraf

Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival.

D. Haraf, Edwardine Nodzenski, David Brachman et al. · PubMed · 1996 · 166 citations

Medicine, Oncology, Pathology +14

Phase I study of docetaxel with concomitant thoracic radiation therapy.

Ann M. Mauer, Gregory A. Masters, D. Haraf et al. · Journal of Clinical Oncology · 1998 · 148 citations

Medicine, Oncology, Radiation Oncology +15

Induction chemotherapy followed by concomitant chemoradiotherapy for advanced head and neck cancer: impact on the natural history of the disease.

Everett E. Vokes, M.S. Kies, D. Haraf et al. · Journal of Clinical Oncology · 1995 · 111 citations

Medicine, Oncology, Radiation Oncology +10

Favorable Long-Term Survival Following Induction Chemotherapy With Cisplatin, Fluorouracil, and Leucovorin and Concomitant Chemoradiotherapy for Locally Advanced Head and Neck Cancer

Everett E. Vokes, R. R. Weichselbaum, Rosemarie Mick et al. · JNCI Journal of the National Cancer Institute · 1992 · 94 citations

Medicine, Oncology, Radiation Oncology +10

Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, and hydroxyurea with granulocyte colony-stimulating factor support for patients with poor-prognosis cancer of the head and neck.

Bruce Brockstein, D. Haraf, K. Stenson et al. · Journal of Clinical Oncology · 1998 · 72 citations

Medicine, Oncology, Radiation Oncology +17